Both Humalog and Novolog are rapid-acting types of insulin used to manage diabetes. But there are important distinctions between Humalog and Novolog, and the drugs are not directly interchangeable.

Humalog (insulin lispro) is a prescription drug that’s prescribed for diabetes in adults and certain children. The drug comes as a liquid solution for subcutaneous injection or intravenous (IV) ...

Humalog (insulin lispro) is a prescription medication used to manage blood sugar levels in people with type 1 and type 2 diabetes. Your doctor will determine the appropriate dosage of Humalog based on ...

NovoLog (insulin aspart) and Humalog (insulin lispro) are brand-name prescription medications. They’re approved by the Food and Drug Administration (FDA) to treat type 1 and type 2 diabetes in certain ...

Eli Lilly said it plans to roll out a half-price version of its Humalog insulin, an effort that comes amid rising scrutiny and criticism over the surging cost of the life-saving medication. The price ...

The change comes on the heels of hearings in Congress where insulin costs were held up for scrutiny. Eli Lilly, under fire for soaring insulin prices, today announced it will introduce an “authorized ...

The U.S. Food and Drug Administration (FDA) has approved Humalog ® 200 units/mL KwikPen ® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's ...

This document is designed to provide you with answers to some common questions about this medicine. It does not contain all the available information and does not take the place of talking with your ...

Eli Lilly has responded to criticism of high prices for insulin products in the US by launching a cut-price version of its Humalog brand. The ‘authorised generic’ uses the same insulin lispro ...

One of the most commonly used insulins just got a price cut. Drugmaker Eli Lilly said on Monday that it will make an "authorized generic" version of the life-saving diabetes medication Humalog, and ...

Eli Lilly says the "net price" for insulin fell to $135 a patient a month in 2018 from $147 in 2014. The insulin's average list price rose 51.9 percent to $594 per patient each month. Pharmaceutical ...